Shir Singer's Colleagues at Mirror Biologics, Inc.
Nicole Lemerond
Board of Directors: Audit Chair, Member of Compensation Committee
Shir Singer's Contact Details
Jerusalem District,Israel
Mirror Biologics, Inc.
Shir Singer's Company Details
Mirror Biologics is an international biopharmaceutical company founded in 2019 and is headquartered in Tampa, Florida where it conducts advanced bioengineering research and development and is establishing a 21 CFR 1271-compliant blood donor and cell processing center. Mirror Biologics operates a GMP cell manufacturing facility in Jerusalem, Israel and has clinical and distribution partner offices in Bangkok, Thailand and Kuala Lumpur, Malaysia. The Mirror Effect technology platform is protected by over 200 patents issued worldwide. The lead drug, AlloStim®, is an "off-the-shelf," non-genetically manipulated, patented, living immune cell differentiated from precursor cells purified from blood of healthy donors and formulated with monoclonal antibody-coated microparticles. The unique feature of AlloStim® is that can imprint a protective or therapeutic cellular immune response that is customized to a patient's resident disease without the need to have prior knowledge of the type of cancer/virus or genetic properties of the disease. Proprietary "artificial lymph node" bioreactors are expected to enable the economical high cell density scale-up of AlloStim® and novel frozen dosage forms enable extended shelf life and economical distribution. Mirror Biologics purchased the exclusive, worldwide rights to AlloStim® and the Mirror Effect technology platform from Immunovative Therapies, Ltd, an Israeli company.